Not independent
Tenure on this board
12.5 yrs
4 nominees · 1 ballot item.
Authorize the Company to sell or otherwise issue shares of common stock at prices below then-current NAV in one or more offerings (each offering limited to up to 25% of outstanding common stock), subject to Board approval and conditions, recommended FOR by management.
Seek shareholder approval to allow the Company, with Board approval and subject to specified conditions, to sell or issue shares of common stock at a price below its then-current NAV in one or more public or private offerings, with each offering limited to no more than 25% of the Company’s then-outstanding common stock and an authorization effective for one year.
This management proposal asks shareholders to approve a one-year authorization allowing the Company, subject to Board approval and specified safeguards, to issue shares of common stock at prices below the then-current NAV in one or more public or private offerings, with each offering capped at no more than 25% of outstanding shares. Management is seeking this authority to provide rapid access to equity capital during periods of market volatility, enabling the Company to pursue attractive investment or acquisition opportunities and to shore up capital to comply with regulatory requirements and debt covenants (notably the 2:1 debt-to-equity constraint under the 1940 Act). The Board emphasizes that such flexibility may prevent forced asset sales at disadvantageous prices and could reduce expenses per share and support dividend sustainability by expanding the asset base. The proposal includes procedural safeguards: a required majority of non-interested and independent directors must determine the transaction is in the Company’s and stockholders’ best interests, and directors must determine in good faith that the sale price closely approximates market value less any distributing commission or discount. Management discloses potential conflicts of interest, noting that increased assets would raise management fees, but the Board concluded benefits outweigh detriments and may consider anti-dilution measures such as rights offerings when appropriate. The authorization places no cap on the discount level but limits the size of each offering to 25% of outstanding shares and is time-limited to one year, which constrains duration but not depth of discounts. For investors, the primary risks include immediate NAV dilution to non-participating holders and potential downward pressure on market price in anticipation of discounted issuances; the proxy provides illustrative dilution scenarios to inform shareholder voting. The Board recommends a FOR vote, arguing that the strategic and balance-sheet flexibility gained justifies the measured risk of dilution given the procedural protections and the opportunistic investment environment the Company may face.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Quantum Portfolio Management LLC | 15.7% | 14,876,741 | $273M |
| 2 | STRS OHIO | 4.6% | 4,347,710 | $80M |
| 3 | Sixth Street Partners Management Company, L.P. | 2.9% | 2,714,226 | $50M |
| 4 | Sound Income Strategies, LLC | 2.7% | 2,571,052 | $47M |
| 5 | Progeny 3, Inc. | 2.6% | 2,476,398 | $46M |
| 6 | OMERS ADMINISTRATION Corp | 2.1% | 1,961,813 | $36M |
| 7 | VAN ECK ASSOCIATES CORP | 1.9% | 1,846,810 | $34M |
| 8 | Allen Investment Management, LLC | 1.5% | 1,395,961 | $26M |
| 9 | ARES MANAGEMENT LLC | 1.4% | 1,354,779 | $25M |
| 10 | UBS Group AG | 1.3% | 1,243,380 | $23M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.